CTCBIO Inc. (KOSDAQ:060590)
South Korea
· Delayed Price · Currency is KRW 6,830.00
+90.00 (1.34%)
At close: May 30, 2025, 3:30 PM KST
CTCBIO Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 144,407 | 137,878 | 165,206 | 140,318 | 130,032 | Upgrade
|
| Other Revenue | -0 | -0 | -0 | -0 | -0 | Upgrade
|
| Revenue | 144,407 | 137,878 | 165,206 | 140,318 | 130,032 | Upgrade
|
| Revenue Growth (YoY) | 4.74% | -16.54% | 17.74% | 7.91% | -4.47% | Upgrade
|
| Cost of Revenue | 91,539 | 95,309 | 111,150 | 107,228 | 103,643 | Upgrade
|
| Gross Profit | 52,868 | 42,570 | 54,056 | 33,090 | 26,389 | Upgrade
|
| Selling, General & Admin | 50,846 | 41,894 | 37,191 | 31,962 | 26,890 | Upgrade
|
| Research & Development | 3,558 | 2,639 | 2,414 | 3,090 | 3,907 | Upgrade
|
| Other Operating Expenses | 317.54 | 264.6 | 208.57 | 231.86 | 203.98 | Upgrade
|
| Operating Expenses | 56,821 | 47,148 | 42,826 | 36,027 | 32,266 | Upgrade
|
| Operating Income | -3,953 | -4,578 | 11,230 | -2,938 | -5,877 | Upgrade
|
| Interest Expense | -3,203 | -3,244 | -2,895 | -3,647 | -4,623 | Upgrade
|
| Interest & Investment Income | 532.28 | 725.08 | 251.11 | 118.76 | 149 | Upgrade
|
| Currency Exchange Gain (Loss) | 318.8 | 41.68 | -470.14 | -533.35 | 396 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,753 | 689.17 | -2,374 | 1,952 | -12,408 | Upgrade
|
| EBT Excluding Unusual Items | -4,552 | -6,367 | 5,741 | -5,047 | -22,362 | Upgrade
|
| Gain (Loss) on Sale of Investments | -186.4 | -201.64 | -320.2 | -708.55 | -1,647 | Upgrade
|
| Gain (Loss) on Sale of Assets | 137.86 | 264.89 | -40.55 | 1.28 | 2,457 | Upgrade
|
| Asset Writedown | -719.3 | -9,411 | -5,181 | -1,337 | -740.28 | Upgrade
|
| Other Unusual Items | - | - | 0.01 | -595.12 | -445.38 | Upgrade
|
| Pretax Income | -5,319 | -15,715 | 199.42 | -7,687 | -22,738 | Upgrade
|
| Income Tax Expense | -99.03 | -126.83 | -4,504 | 291.74 | 130.18 | Upgrade
|
| Earnings From Continuing Operations | -5,220 | -15,588 | 4,704 | -7,978 | -22,868 | Upgrade
|
| Minority Interest in Earnings | - | - | - | 660.21 | 3,411 | Upgrade
|
| Net Income | -5,220 | -15,588 | 4,704 | -7,318 | -19,458 | Upgrade
|
| Net Income to Common | -5,220 | -15,588 | 4,704 | -7,318 | -19,458 | Upgrade
|
| Shares Outstanding (Basic) | 24 | 24 | 24 | 22 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 24 | 24 | 24 | 22 | 20 | Upgrade
|
| Shares Change (YoY) | - | 0.38% | 7.17% | 11.67% | 4.54% | Upgrade
|
| EPS (Basic) | -218.35 | -651.97 | 197.49 | -329.29 | -977.68 | Upgrade
|
| EPS (Diluted) | -218.35 | -652.00 | 197.00 | -329.29 | -978.00 | Upgrade
|
| Free Cash Flow | 2,357 | 6,331 | 15,051 | 4,783 | -1,414 | Upgrade
|
| Free Cash Flow Per Share | 98.58 | 264.80 | 631.92 | 215.23 | -71.04 | Upgrade
|
| Gross Margin | 36.61% | 30.88% | 32.72% | 23.58% | 20.29% | Upgrade
|
| Operating Margin | -2.74% | -3.32% | 6.80% | -2.09% | -4.52% | Upgrade
|
| Profit Margin | -3.62% | -11.31% | 2.85% | -5.21% | -14.96% | Upgrade
|
| Free Cash Flow Margin | 1.63% | 4.59% | 9.11% | 3.41% | -1.09% | Upgrade
|
| EBITDA | 1,951 | 1,368 | 17,936 | 3,344 | -61.44 | Upgrade
|
| EBITDA Margin | 1.35% | 0.99% | 10.86% | 2.38% | -0.05% | Upgrade
|
| D&A For EBITDA | 5,905 | 5,947 | 6,706 | 6,282 | 5,816 | Upgrade
|
| EBIT | -3,953 | -4,578 | 11,230 | -2,938 | -5,877 | Upgrade
|
| EBIT Margin | -2.74% | -3.32% | 6.80% | -2.09% | -4.52% | Upgrade
|
| Advertising Expenses | 1,175 | 1,055 | 636.46 | 722.54 | 361.04 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.